Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites.

Bajaj JS, Weinberg EM, Reddy KR, Keaveny AP, Porayko MK, Koch D, Thuluvath PJ, Simonetto DA, Angeli P, Janardhan SV, Orman ES, Zhang J, Clausen S, Dauphinée E, Palumbo JM, Markham P

Open source

DOI: 10.1097/lvt.0000000000000623
Published: 2025 Oct 1
Container: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/lvt.0000000000000623,
  title = {Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites.},
  author = {Bajaj JS and Weinberg EM and Reddy KR and Keaveny AP and Porayko MK and Koch D and Thuluvath PJ and Simonetto DA and Angeli P and Janardhan SV and Orman ES and Zhang J and Clausen S and Dauphinée E and Palumbo JM and Markham P},
  year = {2025},
  journal = {Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society},
  doi = {10.1097/lvt.0000000000000623},
  url = {https://doi.org/10.1097/lvt.0000000000000623}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites.
AU  - Bajaj JS
AU  - Weinberg EM
AU  - Reddy KR
AU  - Keaveny AP
AU  - Porayko MK
AU  - Koch D
AU  - Thuluvath PJ
AU  - Simonetto DA
AU  - Angeli P
AU  - Janardhan SV
AU  - Orman ES
AU  - Zhang J
AU  - Clausen S
AU  - Dauphinée E
AU  - Palumbo JM
AU  - Markham P
PY  - 2025
JO  - Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
DO  - 10.1097/lvt.0000000000000623
UR  - https://doi.org/10.1097/lvt.0000000000000623
ER  -

APA

JS, B., EM, W., KR, R., AP, K., MK, P., D, K., PJ, T., DA, S., P, A., SV, J., ES, O., J, Z., S, C., E, D., JM, P., & P, M. (2025). Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. https://doi.org/10.1097/lvt.0000000000000623

Source records

pubmed · retrieved 2026-09-26T08:25:18.645Z